Follicular Lymphoma Updates From ASH 2018

Published on

Topics include: Treatment and Understanding

Dr. Neel Gupta speaks with Andrew Schorr about new and improving therapies for Follicular Lymphoma (FL) from ASH 2018. For many Follicular Lymphoma patients, the new treatments are not only life saving but can make this condition make more manageable for many years. Doctors are beginning to be able to treat FL as a chronic condition and do everything that they can to give patients the best quality of life.

We thank Seattle Genetics for their support.

View more programs featuring and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:

Andrew Schorr, on location at the American Society of Hematology meeting, talking about follicular lymphoma and with me is an expert from Stanford University, Dr. Neel Gupta. So, news for people dealing with follicular lymphoma?

Dr. Gupta:        

I think it's an exciting time. We have so many great new treatments available for follicular lymphoma, and a lot of them don’t actually require you receive chemotherapy. So, we're talking about antibody treatments. We're talking about pills that you can take at home that specifically target follicular lymphoma. So, I think this is a golden age in research for follicular lymphoma.

Andrew Schorr:

Okay. So, there have been drugs developed for sort of a similar condition, chronic lymphocytic leukemia. I'm living with it. And then there's a thought, "Can these pills for that work for follicular lymphoma?" What's the thinking?

Dr. Gupta:        

I think the answer's absolutely yes. We're not quite as far as we are with CLL and follicular lymphoma, but we're making strides every year. And I think the science is really driving all of this, and we're finding more and more targets every year to specifically zero in on with pills. And I think within a few years, we won't even be talking about chemotherapy anymore. We'll be talking about taking a pill at home every day.

Andrew Schorr:

Okay. So, if we can't cure follicular lymphoma, do you feel that we're now in the age, and we have been for a while, but really continuing, for more patients to keep at such a low level, you just go on with your life?

Dr. Gupta:        

I think that's exactly right. The way I discuss it with my patients, we think of it as a chronic medical condition, like diabetes or high blood pressure. And our job is to check in with the patients on a periodic basis and make sure their disease is well controlled, so they can live a high-quality life.

Andrew Schorr:

Okay. So, as you investigate some of these oral therapies, someone, if they go to Stanford or another place, should inquire about studies.

Dr. Gupta:        

Absolutely. In fact, that's one of the main reasons to come to a place like Stanford or any other academic center. We have a wide range of clinical trials that might be beneficial, and I think it's very important to ask your doctor about it.

Andrew Schorr:

Okay, thank you. A very hopeful message for people with follicular lymphoma with Dr. Neel Gupta from Stanford, on location in San Diego. I'm Andrew Schorr. Remember, knowledge can be the best medicine of all.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 3, 2019